Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01965665 · ClinicalTrials.gov registry record · NA

Advancing the Standard of Care for Pin Site Care

A NA study of Diabetes Mellitus and Open Reduction External Fixation, sponsored by Duke University.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT01965665 is a NA study of Diabetes Mellitus and Open Reduction External Fixation that has completed, run by Duke University. The registered enrollment target is 20 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01965665, a NA study of Diabetes Mellitus and Open Reduction External Fixation, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to prospectively evaluate the effect of Active Leptospermum honey utilizing the MediHoney HCS dressing, on the occurrence of PIN site infections, and also to see if the use of MediHoney HCS reduces the frequency of dressing changes compared to published reports of routine standard pin site care.

Interventions

  • DEVICE MediHoney HCS dressing

Study Locations (1)

North Carolina

  • Duke University Medical Center/Duke South Clinics/3J - Durham

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2013-10
Est. Completion 2015-06
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT01965665

The ClinicalTrials.gov registry entry for NCT01965665 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which MediHoney HCS dressing is the first listed.

NCT01965665 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT01965665 about?

NCT01965665 is a clinical study titled "Advancing the Standard of Care for Pin Site Care". The purpose of this study is to prospectively evaluate the effect of Active Leptospermum honey utilizing the MediHoney HCS dressing, on the occurrence of PIN site infections, and also to see if the use of MediHoney HCS reduces the frequency of dressing changes compared to published reports of routin...

What is the current status of trial NCT01965665?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-10. Estimated completion is 2015-06.

What conditions does trial NCT01965665 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Open Reduction External Fixation.

What interventions are being tested in trial NCT01965665?

The interventions under investigation include: MediHoney HCS dressing (DEVICE).

Who is sponsoring clinical trial NCT01965665?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01965665 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.